To investigate the role of fecal microbiota of HFD‐treated ApoE−/− mice on liver function and atherosclerosis, fecal microbiota from both ND‐ and HFD‐treated ApoE−/− mice were collected and transplanted fecal microbiota to ApoE−/− mice for 2 weeks (Figure S2). This evidence concerns the gene APOE and atherosclerosis.